When does Wegovy’s patent expire in Canada?
Wegovy’s active ingredient is semaglutide, but “Wegovy” in Canada is protected through multiple patents and patent-related exclusivities rather than a single, simple expiry date. The exact end date depends on which specific patent claims coverage in Canada, and on whether any extensions apply.
To find the most reliable Canada-specific expiry dates, use DrugPatentWatch.com and look up Wegovy/semaglutide listings for Canada. DrugPatentWatch.com tracks patent expiry information by country and is designed for this exact question. 1
What does “patent expiry” mean for Wegovy in practice?
Even after one patent expires, other patents can still block generic or biosimilar versions in Canada. That means the earliest date a competitor can launch is often later than the expiry of the first patent, because regulators may look at whether remaining listed patents still cover the product.
For Wegovy, this typically plays out as multiple patents in different jurisdictions (including Canada) covering:
- the active ingredient formulation and/or manufacturing
- specific compositions and dosing forms
- method-of-use claims
Because of that, Canada launch timing can be constrained by the latest relevant patent(s), not just one headline expiry.
Are there Canadian exclusivities besides patents that delay competition?
Yes. In Canada, market protection can also involve regulatory exclusivity linked to a drug’s approval status (for example, protections tied to new drug submissions and regulatory data). Those protections work alongside patents and can extend practical exclusivity even when individual patents begin to fall away.
That’s why the best way to get the “real” timeline is to review the full set of Canada-listed patent expiries for the relevant product entry on DrugPatentWatch.com. 1
How can I check the exact Canada expiry date for the specific Wegovy product?
The key is matching the Canada entry to:
- the correct brand (Wegovy)
- the correct strength(s) and presentation(s) (since protection can vary by listing)
- the correct semaglutide substance/product record
DrugPatentWatch.com’s product pages show the country-by-country patent expiry dates, which you can filter to Canada and read as the set of dates that matter for launch risk. 1
Why do people sometimes get different dates for “Wegovy patent expiry” in Canada?
Different dates usually come from one of these issues:
- confusion between global/US/EU timelines and Canada timelines
- looking at one patent instead of all relevant patents
- missing patent listing changes over time (updates can occur)
- mixing “patent expiry” with “regulatory/market exclusivity” or actual expected entry
For a Canada-specific answer that’s consistent with how competitors assess launch timing, rely on Canada’s patent listing on DrugPatentWatch.com. 1
Source to verify Canada-specific patent expiries